[go: up one dir, main page]

ES2422563A1 - Composición farmacéutica inyectable de ibuprofeno y arginina, su procedimiento de preparación, forma de dosificación unitaria y utilización de la misma - Google Patents

Composición farmacéutica inyectable de ibuprofeno y arginina, su procedimiento de preparación, forma de dosificación unitaria y utilización de la misma

Info

Publication number
ES2422563A1
ES2422563A1 ES201200240A ES201200240A ES2422563A1 ES 2422563 A1 ES2422563 A1 ES 2422563A1 ES 201200240 A ES201200240 A ES 201200240A ES 201200240 A ES201200240 A ES 201200240A ES 2422563 A1 ES2422563 A1 ES 2422563A1
Authority
ES
Spain
Prior art keywords
ibuprofen
arginine
pharmaceutical composition
injectable pharmaceutical
translation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201200240A
Other languages
English (en)
Other versions
ES2422563B1 (es
Inventor
Menendez Nuria Sanz
Ruiz Angel Munoz
Fernando Martinez-Alzamora
Calvo Antonia Gomez
Martinez Jose Miguel Rizo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmalider SA
Original Assignee
Farmalider SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider SA filed Critical Farmalider SA
Priority to ES201200240A priority Critical patent/ES2422563B1/es
Publication of ES2422563A1 publication Critical patent/ES2422563A1/es
Application granted granted Critical
Publication of ES2422563B1 publication Critical patent/ES2422563B1/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composición farmacéutica inyectable de ibuprofeno y arginina, su procedimiento de preparación, forma de dosificación unitaria y utilización de la misma. La presente invención se refiere a una composición farmacéutica inyectable de ibuprofeno y arginina. En particular, se trata de una solución acuosa que contiene ibuprofeno arginato y un agente isotonizante, que es especialmente adecuada para su administración por vía intravenosa. La presente invención también se refiere a un procedimiento para la preparación de dicha composición, así como a su uso para el tratamiento del dolor agudo moderado, especialmente después de cirugía cuando la administración oral no es adecuada, inflamación y/o fiebre.
ES201200240A 2012-03-08 2012-03-08 Composición farmacéutica inyectable de ibuprofeno y arginina, su procedimiento de preparación, forma de dosificación unitaria y utilización de la misma Active ES2422563B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201200240A ES2422563B1 (es) 2012-03-08 2012-03-08 Composición farmacéutica inyectable de ibuprofeno y arginina, su procedimiento de preparación, forma de dosificación unitaria y utilización de la misma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201200240A ES2422563B1 (es) 2012-03-08 2012-03-08 Composición farmacéutica inyectable de ibuprofeno y arginina, su procedimiento de preparación, forma de dosificación unitaria y utilización de la misma

Publications (2)

Publication Number Publication Date
ES2422563A1 true ES2422563A1 (es) 2013-09-12
ES2422563B1 ES2422563B1 (es) 2014-06-10

Family

ID=49034347

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201200240A Active ES2422563B1 (es) 2012-03-08 2012-03-08 Composición farmacéutica inyectable de ibuprofeno y arginina, su procedimiento de preparación, forma de dosificación unitaria y utilización de la misma

Country Status (1)

Country Link
ES (1) ES2422563B1 (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104622816A (zh) * 2015-01-04 2015-05-20 济南东方开元医药新技术有限公司 一种布洛芬冻干粉针组合物及制备方法
WO2018025128A1 (en) * 2016-08-02 2018-02-08 Jamil Irfan Stable ibuprofen injectable composition

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200558A (en) * 1989-10-17 1993-04-06 Merck & Co., Inc. S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset-hastened enhanced analgesics
WO1995000134A1 (en) * 1993-06-21 1995-01-05 Zambon Group S.P.A. Liquid pharmaceutical composition for oral use containing 2-(4-isobutylphenyl)propionic acid
US6342530B1 (en) * 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
WO2003039532A1 (en) * 2001-11-02 2003-05-15 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
FR2950533A1 (fr) * 2009-09-28 2011-04-01 Maco Pharma Sa Formulation liquide, stable, prete a l'emploi de ketoprofene
CN102100686A (zh) * 2009-12-21 2011-06-22 北京润德康医药技术有限公司 一种含有布洛芬与精氨酸的药用组合物及其制备方法、用途
CN102266285A (zh) * 2010-06-03 2011-12-07 沈阳双鼎科技有限公司 一种低刺激性的布洛芬注射液

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200558A (en) * 1989-10-17 1993-04-06 Merck & Co., Inc. S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset-hastened enhanced analgesics
WO1995000134A1 (en) * 1993-06-21 1995-01-05 Zambon Group S.P.A. Liquid pharmaceutical composition for oral use containing 2-(4-isobutylphenyl)propionic acid
US6342530B1 (en) * 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
WO2003039532A1 (en) * 2001-11-02 2003-05-15 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
FR2950533A1 (fr) * 2009-09-28 2011-04-01 Maco Pharma Sa Formulation liquide, stable, prete a l'emploi de ketoprofene
CN102100686A (zh) * 2009-12-21 2011-06-22 北京润德康医药技术有限公司 一种含有布洛芬与精氨酸的药用组合物及其制备方法、用途
CN102266285A (zh) * 2010-06-03 2011-12-07 沈阳双鼎科技有限公司 一种低刺激性的布洛芬注射液

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Theory and Practice of Contemporary Pharmaceutics; Edited by Tapash K. Ghosh y Bhaskara R. Jasti, CRC Press LLC, 2005, ISBN 0-415-28863-0; páginas 396-398, 406-407. *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104622816A (zh) * 2015-01-04 2015-05-20 济南东方开元医药新技术有限公司 一种布洛芬冻干粉针组合物及制备方法
CN104622816B (zh) * 2015-01-04 2017-05-10 济南东方开元医药新技术有限公司 一种布洛芬冻干粉针组合物及制备方法
WO2018025128A1 (en) * 2016-08-02 2018-02-08 Jamil Irfan Stable ibuprofen injectable composition
CN109843266A (zh) * 2016-08-02 2019-06-04 安巴知识产权有限公司 稳定的布洛芬注射组合物
KR20190062385A (ko) * 2016-08-02 2019-06-05 암바 아이피 리미티드 안정한 이부프로펜 주사용 조성물
US20190183823A1 (en) * 2016-08-02 2019-06-20 Ambah Ip Limited Stable ibuprofen injectable composition
JP2019523292A (ja) * 2016-08-02 2019-08-22 アンバー アイピー リミテッド 安定なイブプロフェン注射製剤用組成物
AU2017307313B2 (en) * 2016-08-02 2021-09-09 Ambah Ip Limited Stable ibuprofen injectable composition
JP2022089867A (ja) * 2016-08-02 2022-06-16 アンバー アイピー リミテッド 安定なイブプロフェン注射製剤用組成物
US11541024B2 (en) * 2016-08-02 2023-01-03 Ambah Ip Limited Stable ibuprofen injectable composition
CN109843266B (zh) * 2016-08-02 2023-08-11 安巴知识产权有限公司 稳定的布洛芬注射组合物
JP7386080B2 (ja) 2016-08-02 2023-11-24 アンバー アイピー リミテッド 安定なイブプロフェン注射製剤用組成物
JP7542028B2 (ja) 2016-08-02 2024-08-29 アンバー アイピー リミテッド 安定なイブプロフェン注射製剤用組成物

Also Published As

Publication number Publication date
ES2422563B1 (es) 2014-06-10

Similar Documents

Publication Publication Date Title
EA201491285A1 (ru) Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты
EA201490377A1 (ru) Лечение рассеянного склероза комбинацией лаквинимода и глатирамера ацетата
PH12016502355A1 (en) Pharmaceutical composition
EA201590450A1 (ru) Сульфамоил-ариламиды и их применение в качестве лекарственных препаратов для лечения гепатита b
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
BR112015022047A8 (pt) uso de uma composição compreendendo nanopartículas contendo um fármaco da família limo e uma albumina
EA201592200A1 (ru) Производные сульфамоилпирроламида и их применение в качестве медикаментов для лечения гепатита b
EA201591166A1 (ru) Ингибиторы аутотаксина
MX2014009757A (es) Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia.
EA201490396A1 (ru) Ингибиторы репликации вирусов гриппа
BR112015022465A2 (pt) método para tratamento não-tóxico para síndrome de abstinência de drogas
AR096892A1 (es) Una combinación farmacéutica para el tratamiento del melanoma
MY191380A (en) Stabilized fixed dose drug composition having mometasone and olopatadine
WO2013138628A3 (en) Injectable ibuprofen formulation
EA201490653A1 (ru) Производные эстра-1,3,5(10),16-тетраен-3-карбоксамида, способ их получения, содержащие их фармацевтические препараты, а также их применение для получения лекарственных средств
EA201692481A1 (ru) Комбинация, содержащая глюкокортикоид и edo-s101
EA201590697A1 (ru) Производные кетамина
TW201613578A (en) Pharmaceutical combinations
MX2016004741A (es) Composicion farmaceutica que comprende un antagonista de trpa1 y un agente analgesico.
BR112015022758A2 (pt) derivados de pirrolidina, composições farmacêuticas contendo os mesmos e seu uso em terapia
MX2017004772A (es) Composiciones y métodos para la administración fisiológica utilizando cannabidiol.
EA201790223A1 (ru) Водный препарат, содержащий парацетамол и ибупрофен
MX2016003522A (es) Derivados de quinazolinas y su uso como inhibidores de la adn metiltransferasa.
PH12016500577A1 (en) Piperazine derivatives and the use thereof as medicament
BR112015018200A2 (pt) composição mastigável para administração oral e processo para preparar a mesma

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2422563

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20140610